| Current status and future directions of cancer immunotherapy |
62 |
| Emerging roles of circRNA in formation and progression of cancer |
48 |
| Awareness of surgical smoke hazards and enhancement of surgical smoke prevention among the gynecologists |
45 |
| Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma |
41 |
| PD-L1 Expression Correlates With Tumor Infiltrating Lymphocytes And Response To Neoadjuvant Chemotherapy In Cervical Cancer |
34 |
| Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis |
31 |
| Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer |
29 |
| LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-135a and Promotes JAK2/STAT3 Signal Pathway in Gastric Cancer |
28 |
| The Role of MicroRNAs in Hepatocellular Carcinoma |
26 |
| The role of Wnt signaling pathway in tumor metabolic reprogramming |
22 |
| High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis |
21 |
| MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors |
21 |
| BRCA Genes: The Role in Genome Stability, Cancer Sternness and Therapy Resistance |
21 |
| MicroRNA-34 family in breast cancer: from research to therapeutic potential |
19 |
| LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression |
18 |
| Exosome-related tumor microenvironment |
18 |
| Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer |
18 |
| The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma |
17 |
| Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications |
17 |
| Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma |
17 |
| The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer |
17 |
| Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma |
16 |
| Epigenetic Field Cancerization in Gastric Cancer: microRNAs as Promising Biomarkers |
16 |
| Clinical significance and diagnostic capacity of serum TK CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients |
16 |
| Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis |
16 |
| Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review |
16 |
| Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer |
16 |
| LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression |
15 |
| Knockdown of long non-coding RNA SNHG5 inhibits malignant cellular phenotypes of glioma via Wnt/CTNNB1 signaling pathway |
15 |
| International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference |
15 |
| Cellular Interactions in the Tumor Microenvironment: The Role of Secretome |
15 |
| Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program |
15 |
| Knockdown of LncRNA RHPN1-AS1 Inhibits Cell Migration, Invasion and Proliferation in Head and Neck Squamous Cell Carcinoma |
15 |
| GPC6 Promotes Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma |
14 |
| miR-149 in Human Cancer: A Systemic Review |
14 |
| Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies |
14 |
| SIRT1 promotes formation of breast cancer through modulating Akt activity |
14 |
| Histone methylation in DNA repair and clinical practice: new findings during the past 5-years |
14 |
| Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-kappa B pathway |
14 |
| Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer |
14 |
| Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells |
14 |
| Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer |
14 |
| Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts |
14 |
| Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan |
13 |
| Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies |
13 |
| Circular RNA Signature in Hepatocellular Carcinoma |
13 |
| Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes? |
13 |
| Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance |
13 |
| CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway |
13 |
| Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma |
13 |
